+84 933 136 996

[email protected]

Giải Pháp Gen
Introduction Description
Introduction

Charité 2019-nCoV BHQ ValuPanel Reagents

Charité 2019-nCoV BHQ™ ValuPanel™ Reagents are now part of the ValuPanel line of detection reagents. ValuPanel Reagents are composed of probes and primers that resolve genetic signatures of different pathogen strains. These signatures target the SARS-CoV-2 virus that causes COVID-19. For Research Use Only. Not for use in diagnostic procedures.

Key benefits

Fast delivery: Product ships in 5 to 7 business days, additional 2-3 business days for EMEA and APAC orders
 Gold standard quencher: From the trusted inventor and original source of Black Hole Quencher™ (BHQ™) technology referenced in 7 of 8 WHO protocols
 Quality manufacture: All probes are HPLC purified. Oligos are manufactured and shipped from a facility entirely separate from positive control production.Quality manufacture: All probes are HPLC purified. Oligos are manufactured and shipped from a facility entirely separate from positive control production.

Charité 2019-nCoV BBQ-650 ValuPanel Reagents

Charité 2019-nCoV BBQ-650 ValuPanel™ Reagents are now part of the ValuPanel line of detection reagents. ValuPanel Reagents are composed of probes and primers that resolve genetic signatures of different pathogen strains. These signatures target the SARS-CoV-2 virus that causes COVID-19. For Research Use Only. Not for use in diagnostic procedures.

Key benefits

 Fast delivery: Product in stock ships same or next business day
 Original source: Berry & Associates, Inventor of BlackBerry™ (BBQ-650™) technology referenced in Charité protocol, is now part of the Biosearch Technologies brand
 Quality manufacture: All probes are HPLC purified. Oligos are manufactured and shipped from a facility entirely separate from positive control production.

US CDC 2019-nCoV ValuPanel Reagents

US CDC 2019-nCoV BHQ™ ValuPanel™ Reagents are now part of the ValuPanel line of detection reagents. ValuPanel Reagents are composed of probes and primers that resolve genetic signatures of different pathogen strains. These signatures target the SARS-CoV-2 virus that causes COVID-19. For Research Use Only. Not for use in diagnostic procedures.
Key benefits

 Fast delivery: Product in stock ships same or next business day
 Gold standard quencher: From the trusted inventor and original source of Black Hole Quencher™ (BHQ™) technology referenced in 7 of 8 WHO protocols
 Quality manufacture: All probes and primers are HPLC purified and are manufactured and shipped from a facility entirely separate from positive control production.

Description

Charité 2019-nCoV BHQ ValuPanel Reagents

Item Sequence
Charite RdRP_SARSr Pan Sarbeco FAM-BHQ Probe FAM-CCAGGTGGWACRTCATCMGGTGATGC-BHQ1
Charite RdRP_SARSr 2019-nCoV FAM-BHQ Probe FAM-CAGGTGGAACCTCATCAGGAGATGC-BHQ1
Charite RdRP_SARSr Forward Primer GTGARATGGTCATGTGTGGCGG
Charite RdRP_SARSr Reverse Primer CARATGTTAAASACACTATTAGCATA
Charite E_Sarbeco FAM-BHQ Probe FAM-ACACTAGCCATCCTTACTGCGCTTCG-BHQ1
Charite E_Sarbeco Forward Primer ACAGGTACGTTAATAGTTAATAGCGT
Charite E_Sarbeco Reverse Primer ATATTGCAGCAGTACGCACACA

Product info

This panel consists of FAM-BHQ probes for use in real-time RT PCR to discriminate SARS-CoV-2 viral strains. This ValuPanel contains probes and primers based on genetic signatures for the following:

RdRP – Confirmatory assay
Pan Sarbeco-Probe to detect 2019-nCoV, SARS-CoV and bat-SARS-related CoVs
Probe specific for 2019-nCoV, will not detect SARS-CoV
E Sarbeco – First line screening assay
Oligonucleotide sequences were designed by German Center for Infection Research (DZIF) at Charité. All probes are labeled with FAM and BHQ dyes, and are HPLC purified.

Charité 2019-nCoV BBQ-650 ValuPanel Reagents

Item Sequence
Charite RdRP_SARSr Pan Sarbeco FAM-BBQ-650 FAM-CCAGGTGGWACRTCATCMGGTGATGC-BBQ650
Charite RdRP_SARSr 2019-nCoV FAM-BBQ-650 Probe FAM-CAGGTGGAACCTCATCAGGAGATGC-BBQ650
Charite RdRP_SARSr Forward Primer GTGARATGGTCATGTGTGGCGG
Charite RdRP_SARSr Reverse Primer CARATGTTAAASACACTATTAGCATA
Charite E_Sarbeco FAM-BBQ-650Probe FAM-ACACTAGCCATCCTTACTGCGCTTCG-BBQ650
Charite E_Sarbeco Forward Primer ACAGGTACGTTAATAGTTAATAGCGT
Charite E_Sarbeco Reverse Primer ATATTGCAGCAGTACGCACACA

Product info

This panel consists of FAM-BBQ-650 probes for use in real-time RT PCR to discriminate SARS-CoV-2 viral strains. This ValuPanel contains probes and primers based on genetic signatures for the following:

RdRP- Confirmatory assay
Pan Sarbeco-Probe to detect 2019-nCoV, SARS-CoV and bat-SARS-related CoVs
Probe specific for 2019-nCoV, will not detect SARS-CoV
E Sarbeco – First line screening assay
Oligonucleotide sequences were designed by German Center for Infection Research (DZIF) at Charité. All probes are labeled with FAM and BlackBerry (BBQ-650) dyes, and are HPLC purified. Berry & Associates, the inventor of BBQ-650 technology, is now part of the Biosearch Technologies brand.

Item Sequence
2019-nCoV_N1 Probe FAM-CCAGGTGGWACRTCATCMGGTGATGC-BBQ650
2019-nCoV_N1 Forward Primer GAC CCC AAA ATC AGC GAA AT
2019-nCoV_N1 Reverse Primer TCT GGT TAC TGC CAG TTG AAT CTG
2019-nCoV_N2 Probe FAM-ACA ATT TGC CCC CAG CGC TTC AG-BHQ1
2019-nCoV_N2 Forward Primer TTA CAA ACA TTG GCC GCA AA
2019-nCoV_N2 Reverse Primer GCG CGA CAT TCC GAA GAA
2019-nCoV_N3 Probe FAM-AYC ACA TTG GCA CCC GCA ATC CTG-BHQ1
2019-nCoV_N3 Forward Primer GGG AGC CTT GAA TAC ACC AAA A
2019-nCoV_N3 Reverse Primer TGT AGC ACG ATT GCA GCA TTG
Human RNase P Extraction Control Probe FAM-TTC TGA CCT GAA GGC TCT GCG CG-BHQ1
Human RNase P Extraction Control Forward Primer AGA TTT GGA CCT GCG AGC G
Human RNase P Extraction Control Reverse Primer GAG CGG CTG TCT CCA CAA GT

Product info

This panel consists of FAM-BHQ probes for use in real-time RT PCR to discriminate SARS-CoV-2 viral strains. This ValuPanel contains probes and primers comprising the following genetic signatures:

N
RNase P
Oligonucleotide sequences were designed by US Centers for Disease Control and Prevention. All probes are labeled with FAM and BHQ dyes, and are HPLC purified.

For more information, click on more info.